Ascendis Pharma Investigational Site

Pittsburgh, Pennsylvania 15232

0 studies enrolling now · 3 studies all time

What they study most

2L+ Cervical Cancer, Advanced Solid Tumor, Endocrine System Diseases, Growth Hormone Deficiency, HPV-associated Cancers, Head and Neck Squamous Cell Carcinoma HNSCC, Hormone Deficiency, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC), Neoadjuvant Melanoma, Neoadjuvant Non-Small Cell Lung Cancer

Studies at this site

• A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency — Completed
• A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors — Stopped early
• A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies — Running, not enrolling